切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2021, Vol. 11 ›› Issue (05) : 286 -290. doi: 10.3877/cma.j.issn.2095-2007.2021.05.006

病例报告

多模态观察急性视网膜坏死一例
卢晓丽1, 罗英子1, 滕月1, 李君慧1, 俞晓艺1,(), 关国华1   
  1. 1. 510405 广州中医药大学第一附属医院眼科
  • 收稿日期:2021-05-09 出版日期:2021-10-28
  • 通信作者: 俞晓艺
  • 基金资助:
    广州中医药大学2019年学科研究重大项目(XK2019015); 关国华全国名老中医药专家传承工作室(国中医药人教教育便函[2018]74号)

One case of acute retinal necrosis by the form of multimodal examination

Xiaoli Lu1, Yingzi Luo1, Yue Teng1   

  • Received:2021-05-09 Published:2021-10-28
引用本文:

卢晓丽, 罗英子, 滕月, 李君慧, 俞晓艺, 关国华. 多模态观察急性视网膜坏死一例[J]. 中华眼科医学杂志(电子版), 2021, 11(05): 286-290.

Xiaoli Lu, Yingzi Luo, Yue Teng. One case of acute retinal necrosis by the form of multimodal examination[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2021, 11(05): 286-290.

图5 患者右眼术后的多光谱眼底图像 图5A示红绿色组合光谱图像;图5B~5H分别示在550 nm、600 nm、620 nm、680 nm、780 nm、810 nm及850 nm波长时的多光谱眼底图像
[1]
Flaxel CJ, Yeh S, Lauer AK. Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis)[J]. Trans Am Ophthalmol Soc, 2013, 111: 133-144.
[2]
Butler NJ, Moradi A, Salek SS, et al. Acute retinal necrosis: presenting characteristics and clinical outcomes in a cohort of polymerase chain reaction-positive patients[J]. Am J Ophthalmol, 2017, 179: 179-189.
[3]
Palay DA, Sternberg PJ, Davis J, et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy[J]. Am J Ophthalmol, 1991, 112(3): 250-255.
[4]
Schoenberger SD, Kim SJ, Thorne JE, et al. Diagnosis and treatment of acute retinal necrosis: a report by the american academy of ophthalmology[J]. Ophthalmology, 2017, 124(3): 382-392.
[5]
Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society[J]. Am J Ophthalmol, 1994, 117(5): 663-667.
[6]
Takase H, Okada AA, Goto H, et al. Development and validation of new diagnostic criteria for acute retinal necrosis[J]. Jpn J Ophthalmol, 2015, 59(1): 14-20.
[7]
Neubauer AS, Yu A, Haritoglou C, et al. Peripheral retinal changes in acute retinal necrosis imaged by ultra widefield scanning laser ophthalmoscopy[J]. Acta Ophthalmol Scand, 2005, 83(6): 758-760.
[8]
曾军,唐朝珍,唐罗生,等. 荧光素眼底血管造影在急性视网膜坏死综合征的临床意义[J]. 中国现代医学杂志2005, 15(10): 1561-1563.
[9]
Suzuki J, Goto H, Minoda H, et al. Analysis of retinal findings of acute retinal necrosis using optical coherence tomography[J]. Ocul Immunol Inflamm, 2006, 14(3): 165-170.
[10]
李娟娟,黎铧,盛智超,等. 急性视网膜坏死光相干断层扫描图像分析[J]. 中国实用眼科杂志201028(3): 247-248.
[11]
Pockar S, Jones NP, Chhabra R, et al. Detection of pre-clinical involvement of the second eye in viral acute retinal necrosis using optical coherence tomography[J]. Ocul Immunol Inflamm, 2020: 1-3.
[12]
Calcagni A, Gibson JM, Styles IB, et al. Multispectral retinal image analysis: a novel non-invasive tool for retinal imaging[J]. Eye (Lond), 2011, 25(12): 1562-1569.
[13]
中国医学装备协会眼科专业委员会. 多光谱眼底分层成像系统的应用标准[J/CD]. 中华眼科医学杂志(电子版)20166(4): 187-192.
[14]
Wong RW, Jumper JM, Mcdonald HR, et al. Emerging concepts in the management of acute retinal necrosis[J]. Br J Ophthalmol, 2013, 97(5): 545-552.
[15]
Cochrane TF, Silvestri G, Mcdowell C, et al. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study[J]. Eye, 2012, 26(3): 370-377, 378.
[16]
Sims JL, Yeoh J, Stawell RJ. Acute retinal necrosis: a case series with clinical features and treatment outcomes[J]. Clin Exp Ophthalmol, 2009, 37(5): 473-477.
[17]
Dokey AT, Haug SJ, Mcdonald HR, et al. Acute retinal necrosis secondary to multidrug-resistant herpes simplex virus 2 in an immunocompetent adolescent[J]. Retin Cases Brief Rep, 2014, 8(4): 260-264.
[18]
Tibbetts MD, Shah CP, Young LH, et al. Treatment of acute retinal necrosis[J]. Ophthalmology, 2010, 117(4): 818-824.
[19]
刘蕴佳,杨培增. 急性视网膜坏死综合征的治疗[J]. 国际眼科杂志201515(5): 813-816.
[20]
Soul-Lawton J, Seaber E, On N, et al. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans[J]. Antimicrob Agents Chemother, 1995, 39(12): 2759-2764.
[21]
Fletcher C, Bean B. Evaluation of oral acyclovir therapy[J]. Drug Intell Clin Pharm, 1985, 19(7-8): 518-524.
[22]
Wong R, Pavesio CE, Laidlaw DA, et al. Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome[J]. Ophthalmology, 2010, 117(3): 556-560.
[23]
郭立斌,孙鼎,叶俊杰,等. 更昔洛韦玻璃体腔注药术治疗急性视网膜坏死[J]. 中华眼科杂志2007, 43(7): 631-637.
[24]
Meghpara B, Sulkowski G, Kesen MR, et al. Long-term follow-up of acute retinal necrosis[J]. Retina, 2010, 30(5): 795-800.
[25]
Kishore K, Jain S, Zarbin MA. Intravitreal ganciclovir and dexamethasone as adjunctive therapy in the management of acute retinal necrosis caused by varicella zoster virus[J]. Ophthalmic Surg Lasers Imaging, 2011, 42: e87-e90.
[26]
Munson PD, Nelson ML, Crawford C, et al. Use of intravitreal triamcinolone for the treatment of optic nerve edema in a patient with acute retinal necrosis: case report[J]. Retin Cases Brief Rep, 2015, 9(2): 102-103.
[27]
Choudhury H, Jindal A, Mithal K, et al. Intravitreal triamcinolone acetonide as an adjuvant in the management of acute retinal necrosis[J]. Can J Ophthalmol, 2014, 49(3): 279-282.
[28]
袁菁,胡维琨. 对比两种给药方案治疗急性视网膜坏死综合征患者的效果[J]. 国际眼科杂志201616(7): 1366-1368.
[29]
de Visser L, de Boer JH, Rijkers GT, et al. Cytokines and chemokines involved in acute retinal necrosis[J]. Invest Ophthalmol Vis Sci, 2017, 58(4): 2139-2151.
[30]
Ortega-Evangelio L, Navarrete-Sanchis J, Williams BK, et al. Aflibercept in the management of acute retinal necrosis syndrome-related macular edema[J]. Eur J Ophthalmol, 2018, 28(2): 259-261.
[31]
Sanchez RA, Pinon MR, Mendieta RN. Response to anti-VEGF therapy in macular oedema secondary to acute retinal necrosis[J]. Arch Soc Esp Oftalmol (Engl Ed), 2019, 94(1): 41-44.
[32]
Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis features, management, and outcomes[J]. Ophthalmology, 2007, 114(4): 756-762.
[33]
Kim DY, Jo J, Joe SG, et al. Clinical feature and visual prognosis of acute retinal necrosis according to the initially involved zone and extent: 10-year experience[J]. Eur J Ophthalmol, 2019, 29(2): 244-250.
[34]
Huang JM, Callanan P, Callanan D, et al. Rate of retinal detachment after early prophylactic vitrectomy for acute retinal necrosis[J]. Ocul Immunol Inflamm, 2018, 26(2): 204-207.
[35]
Luo YH, Duan XC, Chen BH, et al. Efficacy and necessity of prophylactic vitrectomy for acute retinal necrosis syndrome[J]. Int J Ophthalmol, 2012, 5(4): 482-487.
[36]
Ishida T, Sugamoto Y, Sugita S, et al. Prophylactic vitrectomy for acute retinal necrosis[J]. Jpn J Ophthalmol, 2009, 53(5): 486-489.
[37]
Matsuo T. Timing of prophylactic and early vitrectomy for first-presenting or recurrent acute retinal necrosis syndrome[J]. Acta Med Okayama, 2012, 66(6): 493-497.
No related articles found!
阅读次数
全文


摘要